Insider · CIK 0001612859

Kanes Stephen

Reports to the SEC for 2 companies · CHESHIRE

sec.gov

Transactions

Companies

Filings

CIK

0001612859

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−120K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−500K sh	—	—	0
2026-02-02	Centessa Pharmaceuticals plcA Award	Chief Medical Officer	AAward	+120K sh	—	—	120,000
2025-02-03	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Chief Medical Officer	AAward	+500K sh	—	—	500,000
2021-10-19	Sage Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+3,800 sh	—	—	14,591
2021-10-19	Sage Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−1,120 sh	$40.29	−$45.1K	13,471
2021-06-15	Sage Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+3,500 sh	—	—	11,792
2021-06-15	Sage Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−1,001 sh	$58.80	−$58.9K	10,791
2021-02-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+19K sh	—	—	19,000
2020-04-28	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+9,450 sh	—	—	9,450
2020-02-12	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+17.5K sh	—	—	17,500
2019-09-04	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,000 sh	$0.45	+$2,700	8,292
2019-09-04	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,000 sh	—	—	86,100
2019-07-25	Sage Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+1,900 sh	—	—	2,841
2019-07-25	Sage Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−549 sh	$161.38	−$88.6K	2,292
2019-06-21	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+6,600 sh	—	—	13,200
2019-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+19K sh	—	—	19,000
2019-02-08	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−22.9K sh	$150.00	−$3.44M	941
2018-12-07	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+6,600 sh	—	—	6,600
2018-04-02	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+27K sh	—	—	27,000
2017-02-06	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2016-12-08	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+14.4K sh	—	—	68,000
2016-04-20	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+21K sh	$0.45	+$9,450	46,948
2016-04-20	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−21K sh	—	—	112,100
2016-04-19	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−21K sh	$38.00	−$798K	25,948
2016-02-08	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+20K sh	—	—	20,000
2015-09-28	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+21K sh	$0.45	+$9,450	52,948
2015-09-28	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,000 sh	$46.42	−$279K	46,948
2015-09-28	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−21K sh	—	—	133,100
2015-08-31	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−12K sh	$53.12	−$637K	31,948
2015-07-27	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,936 sh	$0.45	+$871.2	48,884
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−500 sh	$72.00	−$36K	48,384
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−800 sh	$69.38	−$55.5K	47,584
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−636 sh	$68.50	−$43.6K	46,948
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−220 sh	$73.64	−$16.2K	46,728
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−826 sh	$72.08	−$59.5K	45,902
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−400 sh	$70.91	−$28.4K	45,502
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−900 sh	$69.60	−$62.6K	44,602
2015-07-27	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−654 sh	$68.67	−$44.9K	43,948
2015-07-27	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,936 sh	—	—	154,100
2015-06-24	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,000 sh	$0.45	+$2,700	52,948
2015-06-24	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,000 sh	$74.06	−$444K	46,948
2015-06-24	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,000 sh	—	—	40,300
2015-03-25	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,400 sh	$51.49	−$278K	46,948
2015-02-25	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,000 sh	$42.05	−$252K	52,348
2015-01-26	Sage Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,000 sh	$37.29	−$224K	58,348
2015-01-23	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+68K sh	—	—	68,000
2014-08-28	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+60.2K sh	$0.45	+$27.1K	63,186
2014-08-28	Sage Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,162 sh	$1.36	+$1,580.32	64,348
2014-08-28	Sage Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−60.2K sh	—	—	162,036

Recent filings

Accepted (ET)
Jun 244
Kanes Stephen0001470831-26-000617
SEC(opens sec.gov)
Feb 34
Kanes Stephen0001470831-26-000098
SEC(opens sec.gov)
Feb 44
Kanes Stephen0001847903-25-000028
SEC(opens sec.gov)
Oct 214
Kanes Stephen0001562180-21-006596
SEC(opens sec.gov)
Jun 174
Kanes Stephen0001562180-21-004338
SEC(opens sec.gov)
Feb 124
Kanes Stephen0001562180-21-001124
SEC(opens sec.gov)
Apr 304
Kanes Stephen0001562180-20-003223
SEC(opens sec.gov)
Feb 144
Kanes Stephen0001562180-20-001246
SEC(opens sec.gov)
Sep 54
Kanes Stephen0001562180-19-004670
SEC(opens sec.gov)
Jul 294
Kanes Stephen0001562180-19-004090
SEC(opens sec.gov)
Jun 254
Kanes Stephen0001562180-19-003640
SEC(opens sec.gov)
Feb 154
Kanes Stephen0001562180-19-001033
SEC(opens sec.gov)
Feb 84
Kanes Stephen0001562180-19-000858
SEC(opens sec.gov)
Dec 114
Kanes Stephen0001562180-18-004912
SEC(opens sec.gov)
Apr 44
Kanes Stephen0001562180-18-001839
SEC(opens sec.gov)

Companies

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, WA14 2DT